Enhanced Digital CBT-I for Insomnia
(COACH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a digital treatment for individuals with insomnia, focusing on participant adherence to the program. The study compares two groups: one using the standard digital program and another receiving additional support from a coach. The goal is to determine what enhances engagement with the treatment. It suits those with persistent sleep difficulties but not those with untreated sleep disorders or severe mental health issues. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance insomnia treatments for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this digital therapy is safe for treating insomnia?
Research has shown that Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) is generally safe and easy for most people to use. Studies have found that this digital method effectively improves sleep for those with sleep issues. Serious side effects rarely occur, and most people manage the treatment well.
Enhanced dCBT-I includes coaching support along with the digital therapy. This added coaching helps people complete the treatment without introducing extra risks. Overall, the therapy is considered safe for most people.12345Why are researchers excited about this trial?
Researchers are excited about Enhanced dCBT-I for insomnia because it combines digital cognitive behavioral therapy with personalized coaching. Unlike standard digital CBT, which patients complete on their own, this treatment offers support from a coach who can address questions and help overcome hurdles. This personalized approach aims to enhance adherence and effectiveness, making it a promising option for those who struggle with traditional self-guided methods.
What evidence suggests that Enhanced dCBT-I might be an effective treatment for insomnia?
Research has shown that digital cognitive behavioral therapy for insomnia (dCBT-I) is effective. Studies have found that 70% to 80% of people experience positive results from CBT-I, with about half seeing a significant reduction in symptoms. Over time, this treatment proves more effective than medication. Digital versions of CBT-I are particularly beneficial for older adults due to their accessibility and lasting benefits. In this trial, participants in the Enhanced dCBT-I arm will receive an improved version of dCBT-I, which includes a coach to enhance commitment and outcomes through personal support. Meanwhile, participants in the Control dCBT-I arm will complete dCBT-I individually without assistance from a healthcare provider.14678
Who Is on the Research Team?
Philip A Cheng, PhD
Principal Investigator
Henry Ford Health System
Are You a Good Fit for This Trial?
This trial is for adults with insomnia, as indicated by an Insomnia Severity Index (ISI) score over 14. It's not suitable for individuals under 18, those unwilling or unable to participate, or people with bipolar or seizure disorders. Also excluded are those with untreated sleep disorders other than insomnia and severe medical or psychiatric conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 6 weekly sessions of Digital Cognitive Behavioral Treatment for Insomnia (dCBT-I). Enhanced group receives additional telehealth coaching.
Follow-up
Participants are monitored for adherence and treatment engagement, including semi-structured interviews for some participants.
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced dCBT-I
Enhanced dCBT-I is already approved in United States, United Kingdom for the following indications:
- Insomnia
- Insomnia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Henry Ford Health System
Lead Sponsor
University of Michigan
Collaborator
National Jewish Health
Collaborator